Results 81 to 90 of about 3,391 (207)

Treatment of the Raynaud's phenomenon with piracetam.

open access: yes, 1993
Piracetam (Nootropil, CAS 7491-74-9) has been investigated in the treatment of primary and secondary Raynaud's phenomenon in three sequential and complementary studies.
Lavenne-Pardonge, E.   +4 more
core  

Prevention of disorders of behavioral reactions in rats using nootropics with sodium valproate [PDF]

open access: yesMedičnì Perspektivi, 2013
Using of anticonvulsants can trigger a number of side effects, such as possible changes in behavior and emotional state of people with epilepsy, risk of unwarranted aggression, nervousness, discoordination, sleepiness, encephalopathies.
Ivanov A.V.
doaj  

The Effects of Nootropic Drugs on Striatal 5-HT2A-Receptors in Outbred Mice with Different Efficacy of Exploratory Behavior

open access: yesФармакокинетика и Фармакодинамика, 2019
Resume. The effect of subchronic administration of nootropic drugs of different structures (piracetam 200 mg/kg/day, pantocalcin 200 mg/kg/day, semax 0.6 mg/ kg/day, nooglutil 50 mg/kg/day) to mice of the outbred line 1CR on spontaneous research activity
Yu. Yu. Firstova   +2 more
doaj   +1 more source

Analgesic activity of piracetam: Effect on cytokine production and oxidative stress

open access: yes, 2013
Piracetam is a prototype of nootropic drugs used to improve cognitive impairment. However, recent studies suggest that piracetam can have analgesic and anti-inflammatory effects.
Mizokami, Sandra S.   +5 more
core   +1 more source

Extended Delirium Treated as Psychosis

open access: yesAnnals of Indian Psychiatry
Delirium is a commonly seen neuropsychiatric disorder that may extend over time, lasting for more than 60 days, thus increasing the risk of cognitive and behavioral outcomes in patients.
Neena Sawant   +3 more
doaj   +1 more source

Chronic cerebral circulatory disorders: possibilities of enhancing the efficiency of therapy

open access: yesНеврология, нейропсихиатрия, психосоматика, 2017
Chronic cerebral circulatory disorders (CCCDs) are a group of syndromes manifested by cognitive, emotional disturbances and less commonly motor and sensory neurological symptoms, which is heterogeneous in the mechanisms of development.
P. R. Kamchatnov   +2 more
doaj   +1 more source

Place of piracetam in the modern practice of medicine

open access: yes, 2017
The review considers the stages of experimental and clinical study of piracetam in the framework of evidence-based medicine, its wide practical application in various fields of clinical medicine. The main attention pays to the mechanisms of action of the
Victor V Vostrikov
core   +1 more source

Effect of Jyotiṣmatī seed oil on spatial and fear memory using scopolamine induced amnesia in mice

open access: yesAncient Science of Life, 2015
Background: Treatment of memory impairment associated with dementia such as Alzheimer′s disease is still inadequate and requires development of new drugs. Objective: The objective was to evaluate the memory enhancing effect of Celastrus paniculatus seed
Sanket B Raut   +4 more
doaj   +1 more source

Reduction of cognitive performance by piracetam in patients undergoing coronary bypass surgery using heart-lung maschine

open access: yes, 2015
Einleitung: Das Auftreten von kognitiven Funktionsstörungen nach koronaren Bypass-Operationen ist eine bedeutende klinische Problematik. Die genaue Pathophysiologie der postoperativen kognitiven Dysfunktion ist nicht abschließend geklärt, eine ...
Alaaraj, Nour
core   +1 more source

Home - About - Disclaimer - Privacy